Gasparotto, M.; Hernandez Gomez, Y.S.; Peterle, D.; Grinzato, A.; Zen, F.; Pontarollo, G.; Acquasaliente, L.; Scapin, G.; Bergantino, E.; De Filippis, V.;
et al. NOG-Derived Peptides Can Restore Neuritogenesis on a CRASH Syndrome Cell Model. Biomedicines 2022, 10, 102.
https://doi.org/10.3390/biomedicines10010102
AMA Style
Gasparotto M, Hernandez Gomez YS, Peterle D, Grinzato A, Zen F, Pontarollo G, Acquasaliente L, Scapin G, Bergantino E, De Filippis V,
et al. NOG-Derived Peptides Can Restore Neuritogenesis on a CRASH Syndrome Cell Model. Biomedicines. 2022; 10(1):102.
https://doi.org/10.3390/biomedicines10010102
Chicago/Turabian Style
Gasparotto, Matteo, Yuriko Suemi Hernandez Gomez, Daniele Peterle, Alessandro Grinzato, Federica Zen, Giulia Pontarollo, Laura Acquasaliente, Giorgia Scapin, Elisabetta Bergantino, Vincenzo De Filippis,
and et al. 2022. "NOG-Derived Peptides Can Restore Neuritogenesis on a CRASH Syndrome Cell Model" Biomedicines 10, no. 1: 102.
https://doi.org/10.3390/biomedicines10010102
APA Style
Gasparotto, M., Hernandez Gomez, Y. S., Peterle, D., Grinzato, A., Zen, F., Pontarollo, G., Acquasaliente, L., Scapin, G., Bergantino, E., De Filippis, V., & Filippini, F.
(2022). NOG-Derived Peptides Can Restore Neuritogenesis on a CRASH Syndrome Cell Model. Biomedicines, 10(1), 102.
https://doi.org/10.3390/biomedicines10010102
